495 related articles for article (PubMed ID: 19430488)
41. GPR30 activation improves memory and facilitates DHPG-induced LTD in the hippocampal CA3 of middle-aged mice.
Xu W; Cao J; Zhou Y; Wang L; Zhu G
Neurobiol Learn Mem; 2018 Mar; 149():10-19. PubMed ID: 29421611
[TBL] [Abstract][Full Text] [Related]
42. Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?
Comeglio P; Morelli A; Cellai I; Vignozzi L; Sarchielli E; Filippi S; Maneschi E; Corcetto F; Corno C; Gacci M; Vannelli GB; Maggi M
Prostate; 2014 Jan; 74(1):10-28. PubMed ID: 24037776
[TBL] [Abstract][Full Text] [Related]
43. Sweroside promotes osteoblastic differentiation and mineralization via interaction of membrane estrogen receptor-α and GPR30 mediated p38 signalling pathway on MC3T3-E1 cells.
Wu QC; Tang XY; Dai ZQ; Dai Y; Xiao HH; Yao XS
Phytomedicine; 2020 Mar; 68():153146. PubMed ID: 32028183
[TBL] [Abstract][Full Text] [Related]
44. The unfolding stories of GPR30, a new membrane-bound estrogen receptor.
Maggiolini M; Picard D
J Endocrinol; 2010 Feb; 204(2):105-14. PubMed ID: 19767412
[TBL] [Abstract][Full Text] [Related]
45. The G-protein-coupled estrogen receptor GPER in health and disease.
Prossnitz ER; Barton M
Nat Rev Endocrinol; 2011 Aug; 7(12):715-26. PubMed ID: 21844907
[TBL] [Abstract][Full Text] [Related]
46. G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis.
Sharma G; Prossnitz ER
Adv Exp Med Biol; 2017; 1043():427-453. PubMed ID: 29224106
[TBL] [Abstract][Full Text] [Related]
47. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.
Albanito L; Sisci D; Aquila S; Brunelli E; Vivacqua A; Madeo A; Lappano R; Pandey DP; Picard D; Mauro L; Andò S; Maggiolini M
Endocrinology; 2008 Aug; 149(8):3799-808. PubMed ID: 18467441
[TBL] [Abstract][Full Text] [Related]
48. Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30.
Revankar CM; Mitchell HD; Field AS; Burai R; Corona C; Ramesh C; Sklar LA; Arterburn JB; Prossnitz ER
ACS Chem Biol; 2007 Aug; 2(8):536-44. PubMed ID: 17655271
[TBL] [Abstract][Full Text] [Related]
49. Estrogen signaling characteristics of Atlantic croaker G protein-coupled receptor 30 (GPR30) and evidence it is involved in maintenance of oocyte meiotic arrest.
Pang Y; Dong J; Thomas P
Endocrinology; 2008 Jul; 149(7):3410-26. PubMed ID: 18420744
[TBL] [Abstract][Full Text] [Related]
50. New roles for neuronal estrogen receptors.
Lu CL; Herndon C
Neurogastroenterol Motil; 2017 Jul; 29(7):. PubMed ID: 28597596
[TBL] [Abstract][Full Text] [Related]
51. G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity.
Meyer MR; Fredette NC; Barton M; Prossnitz ER
J Endocrinol; 2015 Oct; 227(1):61-9. PubMed ID: 26303299
[TBL] [Abstract][Full Text] [Related]
52. The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice.
Windahl SH; Andersson N; Chagin AS; Mårtensson UE; Carlsten H; Olde B; Swanson C; Movérare-Skrtic S; Sävendahl L; Lagerquist MK; Leeb-Lundberg LM; Ohlsson C
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E490-6. PubMed ID: 19088255
[TBL] [Abstract][Full Text] [Related]
53. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption.
Thomas P; Dong J
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):175-9. PubMed ID: 17088055
[TBL] [Abstract][Full Text] [Related]
54. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis.
Blasko E; Haskell CA; Leung S; Gualtieri G; Halks-Miller M; Mahmoudi M; Dennis MK; Prossnitz ER; Karpus WJ; Horuk R
J Neuroimmunol; 2009 Sep; 214(1-2):67-77. PubMed ID: 19664827
[TBL] [Abstract][Full Text] [Related]
55. G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer.
Liu C; Liao Y; Fan S; Fu X; Xiong J; Zhou S; Zou M; Wang J
Oncol Res; 2019 Feb; 27(3):283-292. PubMed ID: 28877783
[TBL] [Abstract][Full Text] [Related]
56. Soy Isoflavones Accelerate Glial Cell Migration
Ariyani W; Miyazaki W; Amano I; Hanamura K; Shirao T; Koibuchi N
Front Endocrinol (Lausanne); 2020; 11():554941. PubMed ID: 33250856
[TBL] [Abstract][Full Text] [Related]
57. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
58. Possible role of phytoestrogens in breast cancer via GPER-1/GPR30 signaling.
Molina L; Bustamante FA; Bhoola KD; Figueroa CD; Ehrenfeld P
Clin Sci (Lond); 2018 Dec; 132(24):2583-2598. PubMed ID: 30545896
[TBL] [Abstract][Full Text] [Related]
59. Estrogens induce rapid cytoskeleton re-organization in human dermal fibroblasts via the non-classical receptor GPR30.
Carnesecchi J; Malbouyres M; de Mets R; Balland M; Beauchef G; Vié K; Chamot C; Lionnet C; Ruggiero F; Vanacker JM
PLoS One; 2015; 10(3):e0120672. PubMed ID: 25781607
[TBL] [Abstract][Full Text] [Related]
60. Assessment of cell line competence for studies of pharmacological GPR30 modulation.
Sousa C; Ribeiro M; Rufino AT; Leitão AJ; Mendes AF
J Recept Signal Transduct Res; 2017 Apr; 37(2):181-188. PubMed ID: 27401115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
